{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:49:55Z","timestamp":1782902995098,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the \"Pioneer\" and \"Leading Goose\" R&D Program of Zhejiang","award":["2023C03075"],"award-info":[{"award-number":["2023C03075"]}]},{"name":"Project of Applied Basic Research on Medical and Health Science and Technology Innovation of Suzhou","award":["SKY2023113"],"award-info":[{"award-number":["SKY2023113"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172336"],"award-info":[{"award-number":["82172336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Fluoresc"],"DOI":"10.1007\/s10895-025-04620-4","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:23:24Z","timestamp":1763756604000},"page":"1341-1352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment of a Time-Resolved Fluoroimmunoassay for sC5b-9 and Validation in Lupus Nephritis"],"prefix":"10.1007","volume":"36","author":[{"given":"Bin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangbin","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"4620_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS et al (2015) Complement system part I - Molecular mechanisms of activation and regulation. Front Immunol 6:262. https:\/\/doi.org\/10.3389\/fimmu.2015.00262","journal-title":"Front Immunol"},{"key":"4620_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00257","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS et al (2015) Complement system part II: role in immunity. Front Immunol 6:257. https:\/\/doi.org\/10.3389\/fimmu.2015.00257","journal-title":"Front Immunol"},{"issue":"6","key":"4620_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","volume":"43","author":"RB Pouw","year":"2021","unstructured":"Pouw RB, Ricklin D (2021) Tipping the balance: intricate roles of the complement system in disease and therapy. Semin Immunopathol 43(6):757\u2013771. https:\/\/doi.org\/10.1007\/s00281-021-00892-7","journal-title":"Semin Immunopathol"},{"key":"4620_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585108","volume":"11","author":"SR Barnum","year":"2020","unstructured":"Barnum SR, Bubeck D, Schein TN (2020) Soluble membrane attack complex: biochemistry and immunobiology. Front Immunol 11:585108. https:\/\/doi.org\/10.3389\/fimmu.2020.585108","journal-title":"Front Immunol"},{"issue":"1","key":"4620_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/imr.12461","volume":"274","author":"BP Morgan","year":"2016","unstructured":"Morgan BP et al (2016) Terminal complexes of the complement system: new structural insights and their relevance to function. Immunol Rev 274(1):141\u2013151. https:\/\/doi.org\/10.1111\/imr.12461","journal-title":"Immunol Rev"},{"issue":"6","key":"4620_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.imbio.2015.04.006","volume":"221","author":"BP Morgan","year":"2016","unstructured":"Morgan BP (2016) The membrane attack complex as an inflammatory trigger. Immunobiology 221(6):747\u2013751. https:\/\/doi.org\/10.1016\/j.imbio.2015.04.006","journal-title":"Immunobiology"},{"issue":"2","key":"4620_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/imm.12556","volume":"147","author":"M Triantafilou","year":"2016","unstructured":"Triantafilou M et al (2016) Complementing the inflammasome. Immunology 147(2):152\u2013164. https:\/\/doi.org\/10.1111\/imm.12556","journal-title":"Immunology"},{"key":"4620_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.semcdb.2017.06.009","volume":"72","author":"BP Morgan","year":"2017","unstructured":"Morgan BP, Boyd C, Bubeck D (2017) Molecular cell biology of complement membrane attack. Semin Cell Dev Biol 72:124\u2013132. https:\/\/doi.org\/10.1016\/j.semcdb.2017.06.009","journal-title":"Semin Cell Dev Biol"},{"key":"4620_CR9","doi-asserted-by":"publisher","first-page":"599974","DOI":"10.3389\/fimmu.2020.599974","volume":"11","author":"JJE Koopman","year":"2020","unstructured":"Koopman JJE et al (2020) Deposition of the membrane attack complex in healthy and diseased human kidneys. Front Immunol 11:599974. https:\/\/doi.org\/10.3389\/fimmu.2020.599974","journal-title":"Front Immunol"},{"issue":"11","key":"4620_CR10","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1016\/j.ekir.2024.08.009","volume":"9","author":"S Kissling","year":"2024","unstructured":"Kissling S et al (2024) Urinary sC5b-9 is better linked to albuminuria than to intrarenal inflammation in common kidney disease. Kidney Int Rep 9(11):3335\u20133337. https:\/\/doi.org\/10.1016\/j.ekir.2024.08.009","journal-title":"Kidney Int Rep"},{"issue":"11","key":"4620_CR11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/nbt1344","volume":"25","author":"RP Rother","year":"2007","unstructured":"Rother RP et al (2007) Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol 25(11):1256\u20131264. https:\/\/doi.org\/10.1038\/nbt1344","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4620_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.tmrv.2019.09.004","volume":"33","author":"CJ Patriquin","year":"2019","unstructured":"Patriquin CJ, Kuo KHM (2019) Eculizumab and beyond: the past, present, and future of complement therapeutics. Transfus Med Rev 33(4):256\u2013265. https:\/\/doi.org\/10.1016\/j.tmrv.2019.09.004","journal-title":"Transfus Med Rev"},{"issue":"18","key":"4620_CR13","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1182\/blood.2020009280","volume":"137","author":"F Fakhouri","year":"2021","unstructured":"Fakhouri F et al (2021) Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study. Blood 137(18):2438\u20132449. https:\/\/doi.org\/10.1182\/blood.2020009280","journal-title":"Blood"},{"issue":"6","key":"4620_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","volume":"13","author":"D Erkan","year":"2014","unstructured":"Erkan D et al (2014) 14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Autoimmun Rev 13(6):685\u2013696. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.053","journal-title":"Autoimmun Rev"},{"issue":"5","key":"4620_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.semnephrol.2015.08.006","volume":"35","author":"DJ Birmingham","year":"2015","unstructured":"Birmingham DJ, Hebert LA (2015) The complement system in lupus nephritis. Semin Nephrol 35(5):444\u2013454. https:\/\/doi.org\/10.1016\/j.semnephrol.2015.08.006","journal-title":"Semin Nephrol"},{"issue":"1","key":"4620_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/j.ajkd.2014.07.031","volume":"65","author":"A El-Husseini","year":"2015","unstructured":"El-Husseini A et al (2015) Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab. Am J Kidney Dis 65(1):127\u2013130. https:\/\/doi.org\/10.1053\/j.ajkd.2014.07.031","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"4620_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/ki.1995.197","volume":"47","author":"T Lehto","year":"1995","unstructured":"Lehto T et al (1995) Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int 47(5):1403\u20131411. https:\/\/doi.org\/10.1038\/ki.1995.197","journal-title":"Kidney Int"},{"key":"4620_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011166","author":"J Zipperle","year":"2024","unstructured":"Zipperle J et al (2024) Effect of unfractionated heparin dose on complement activation and selected extracellular vesicle populations during extracorporeal membrane oxygenation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252011166","journal-title":"Int J Mol Sci"},{"issue":"1\u20133","key":"4620_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0022-1759(83)90088-1","volume":"57","author":"S Bhakdi","year":"1983","unstructured":"Bhakdi S, Muhly M (1983) A simple immunoradiometric assay for the terminal SC5b-9 complex of human complement. J Immunol Methods 57(1\u20133):283\u2013289. https:\/\/doi.org\/10.1016\/0022-1759(83)90088-1","journal-title":"J Immunol Methods"},{"issue":"2","key":"4620_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0003-2697(84)90095-2","volume":"137","author":"I Hemmil\u00e4","year":"1984","unstructured":"Hemmil\u00e4 I et al (1984) Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 137(2):335\u2013343. https:\/\/doi.org\/10.1016\/0003-2697(84)90095-2","journal-title":"Anal Biochem"},{"key":"4620_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cplett.2017.03.046","volume":"676","author":"R Singh","year":"2017","unstructured":"Singh R et al (2017) An excellent stable fluorescent probe: selective and sensitive detection of trace amounts of Hg\u2009+\u20092 ions in natural source of water. Chem Phys Lett 676:39\u201345. https:\/\/doi.org\/10.1016\/j.cplett.2017.03.046","journal-title":"Chem Phys Lett"},{"issue":"6","key":"4620_CR22","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s10895-020-02589-w","volume":"30","author":"R Singh","year":"2020","unstructured":"Singh R et al (2020) Spectroscopic studies of CDPy molecule in different protic and aprotic solvents and investigation of antioxidant property. J Fluoresc 30(6):1439\u20131446. https:\/\/doi.org\/10.1007\/s10895-020-02589-w","journal-title":"J Fluoresc"},{"issue":"2","key":"4620_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1681\/asn.V102413","volume":"10","author":"JS Cameron","year":"1999","unstructured":"Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10(2):413\u2013424. https:\/\/doi.org\/10.1681\/asn.V102413","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"4620_CR24","first-page":"S29","volume":"12","author":"JS Cameron","year":"1999","unstructured":"Cameron JS (1999) Lupus nephritis: an historical perspective 1968\u20131998. J Nephrol 12(Suppl 2):S29\u201341","journal-title":"J Nephrol"},{"issue":"3","key":"4620_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/01.md.0000224709.70133.f7","volume":"85","author":"N Kasitanon","year":"2006","unstructured":"Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Med Baltim 85(3):147\u2013156. https:\/\/doi.org\/10.1097\/01.md.0000224709.70133.f7","journal-title":"Med Baltim"},{"issue":"5","key":"4620_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/0961203309358187","volume":"19","author":"LM Ortega","year":"2010","unstructured":"Ortega LM et al (2010) Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 19(5):557\u2013574. https:\/\/doi.org\/10.1177\/0961203309358187","journal-title":"Lupus"},{"issue":"5","key":"4620_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/s0272-6386(00)70262-9","volume":"35","author":"SM Korbet","year":"2000","unstructured":"Korbet SM et al (2000) Factors predictive of outcome in severe lupus nephritis. Lupus nephritis collaborative study group. Am J Kidney Dis 35(5):904\u2013914. https:\/\/doi.org\/10.1016\/s0272-6386(00)70262-9","journal-title":"Am J Kidney Dis"},{"issue":"3844","key":"4620_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1126\/science.161.3844.904","volume":"161","author":"T Tojo","year":"1968","unstructured":"Tojo T, Friou GJ (1968) Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei. Science 161(3844):904\u2013906. https:\/\/doi.org\/10.1126\/science.161.3844.904","journal-title":"Science"},{"issue":"6","key":"4620_CR29","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1084\/jem.154.6.1779","volume":"154","author":"G Biesecker","year":"1981","unstructured":"Biesecker G, Katz S, Koffler D (1981) Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. J Exp Med 154(6):1779\u20131794. https:\/\/doi.org\/10.1084\/jem.154.6.1779","journal-title":"J Exp Med"},{"issue":"3","key":"4620_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1046\/j.1365-2249.1996.d01-776.x","volume":"105","author":"JE Teixeira","year":"1996","unstructured":"Teixeira JE et al (1996) CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients. Clin Exp Immunol 105(3):497\u2013503. https:\/\/doi.org\/10.1046\/j.1365-2249.1996.d01-776.x","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"4620_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000189529","volume":"75","author":"S Mosolits","year":"1997","unstructured":"Mosolits S, Magyarlaki T, Nagy J (1997) Membrane attack complex and membrane cofactor protein are related to tubulointerstitial inflammation in various human glomerulopathies. Nephron 75(2):179\u2013187. https:\/\/doi.org\/10.1159\/000189529","journal-title":"Nephron"},{"issue":"8","key":"4620_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.humimm.2013.04.030","volume":"74","author":"RM Nisihara","year":"2013","unstructured":"Nisihara RM et al (2013) Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients. Hum Immunol 74(8):907\u2013910. https:\/\/doi.org\/10.1016\/j.humimm.2013.04.030","journal-title":"Hum Immunol"},{"key":"4620_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2018.05.034","volume":"32","author":"H Ma","year":"2018","unstructured":"Ma H et al (2018) Mesenchymal stem cells control complement C5 activation by factor H in lupus nephritis. EBioMedicine 32:21\u201330. https:\/\/doi.org\/10.1016\/j.ebiom.2018.05.034","journal-title":"EBioMedicine"},{"issue":"2","key":"4620_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.semarthrit.2018.01.004","volume":"48","author":"S Wang","year":"2018","unstructured":"Wang S et al (2018) Membrane attack complex (MAC) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment. Semin Arthritis Rheum 48(2):256\u2013262. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.01.004","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"4620_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.kint.2018.09.027","volume":"95","author":"HR Wilson","year":"2019","unstructured":"Wilson HR et al (2019) Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis. Kidney Int 95(3):655\u2013665. https:\/\/doi.org\/10.1016\/j.kint.2018.09.027","journal-title":"Kidney Int"},{"issue":"3","key":"4620_CR36","first-page":"787","volume":"12","author":"D Seiffert","year":"1997","unstructured":"Seiffert D (1997) Constitutive and regulated expression of vitronectin. Histol Histopathol 12(3):787\u2013797","journal-title":"Histol Histopathol"},{"key":"4620_CR37","doi-asserted-by":"publisher","unstructured":"Falgarone G, Chiocchia G (2009) Chap. 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity. Adv Cancer Res 104:139\u201370. https:\/\/doi.org\/10.1016\/s0065-230x(09)04008-1","DOI":"10.1016\/s0065-230x(09)04008-1"},{"issue":"24","key":"4620_CR38","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","volume":"123","author":"SR Cataland","year":"2014","unstructured":"Cataland SR et al (2014) Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP. Blood 123(24):3733\u20133738. https:\/\/doi.org\/10.1182\/blood-2013-12-547067","journal-title":"Blood"},{"issue":"11","key":"4620_CR39","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","volume":"124","author":"M Noris","year":"2014","unstructured":"Noris M et al (2014) Dynamics of complement activation in aHUS and how to monitor Eculizumab therapy. Blood 124(11):1715\u20131726. https:\/\/doi.org\/10.1182\/blood-2014-02-558296","journal-title":"Blood"},{"issue":"6","key":"4620_CR40","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1053\/j.ajkd.2015.02.326","volume":"65","author":"F Bu","year":"2015","unstructured":"Bu F et al (2015) Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome. Am J Kidney Dis 65(6):968\u2013969. https:\/\/doi.org\/10.1053\/j.ajkd.2015.02.326","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4620_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/cei.12426","volume":"181","author":"EB Volokhina","year":"2015","unstructured":"Volokhina EB et al (2015) Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission. Clin Exp Immunol 181(2):306\u2013313. https:\/\/doi.org\/10.1111\/cei.12426","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"4620_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40291-022-00620-3","volume":"27","author":"TJ Cammett","year":"2023","unstructured":"Cammett TJ et al (2023) Exploratory prognostic biomarkers of Complement-Mediated thrombotic microangiopathy (CM-TMA) in adults with atypical hemolytic uremic syndrome (aHUS): analysis of a phase III study of ravulizumab. Mol Diagn Ther 27(1):61\u201374. https:\/\/doi.org\/10.1007\/s40291-022-00620-3","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"4620_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ki.1994.59","volume":"45","author":"L Biancone","year":"1994","unstructured":"Biancone L et al (1994) Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 45(2):451\u2013460. https:\/\/doi.org\/10.1038\/ki.1994.59","journal-title":"Kidney Int"},{"issue":"10","key":"4620_CR44","doi-asserted-by":"publisher","first-page":"e0275016","DOI":"10.1371\/journal.pone.0275016","volume":"17","author":"JAR Guimar\u00e3es","year":"2022","unstructured":"Guimar\u00e3es JAR et al (2022) Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews. PLoS ONE 17(10):e0275016. https:\/\/doi.org\/10.1371\/journal.pone.0275016","journal-title":"PLoS ONE"},{"key":"4620_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195759","author":"L Palazzo","year":"2022","unstructured":"Palazzo L et al (2022) Current insights on biomarkers in lupus nephritis: a systematic review of the literature. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11195759","journal-title":"J Clin Med"},{"key":"4620_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bios.2017.10.017","volume":"101","author":"R Singh","year":"2018","unstructured":"Singh R et al (2018) QPRTase modified N-doped carbon quantum dots: a fluorescent bioprobe for selective detection of neurotoxin quinolinic acid in human serum. Biosens Bioelectron 101:103\u2013109. https:\/\/doi.org\/10.1016\/j.bios.2017.10.017","journal-title":"Biosens Bioelectron"},{"issue":"6","key":"4620_CR47","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s10895-020-02603-1","volume":"30","author":"R Singh","year":"2020","unstructured":"Singh R, Singh RK (2020) Detection of malachite green in water using edge excited label free fluorescent probe NCQDs. J Fluoresc 30(6):1281\u20131285. https:\/\/doi.org\/10.1007\/s10895-020-02603-1","journal-title":"J Fluoresc"},{"key":"4620_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00837","volume":"11","author":"B Huang","year":"2020","unstructured":"Huang B et al (2020) Phospholipase A2 receptor autoantibodies as a novel serological biomarker for autoimmune thyroid disease associated nephropathy. Front Immunol 11:837. https:\/\/doi.org\/10.3389\/fimmu.2020.00837","journal-title":"Front Immunol"},{"issue":"1","key":"4620_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.aca.2006.04.053","volume":"571","author":"B Huang","year":"2006","unstructured":"Huang B et al (2006) Ultrasensitive detection of pepsinogen I and pepsinogen II by a time-resolved fluoroimmunoassay and its preliminary clinical applications. Anal Chim Acta 571(1):74\u201378. https:\/\/doi.org\/10.1016\/j.aca.2006.04.053","journal-title":"Anal Chim Acta"}],"container-title":["Journal of Fluorescence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-025-04620-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10895-025-04620-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-025-04620-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:31:01Z","timestamp":1773235861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10895-025-04620-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4620"],"URL":"https:\/\/doi.org\/10.1007\/s10895-025-04620-4","relation":{},"ISSN":["1573-4994"],"issn-type":[{"value":"1573-4994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants prior to the study. The research protocol was approved by the Ethics Committee of Southwest Hospital, Chongqing (Scientific Research Ethics Committee, Approval Number KY2024264).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}